Non-Vitamin K Oral Anticoagulants in Adults with Congenital Heart Disease: A Systematic Review
Ontology highlight
ABSTRACT: Adults with congenital heart disease (ACHD) experience more thromboembolic complications than the general population. We systematically searched and critically appraised all studies on the safety and efficacy of non-vitamin-K oral anticoagulants (NOACs) in adult patients with various forms of congenital heart disease. PubMed and the Cochrane Central Register of Controlled Trials (CENTRAL) were used, with duplicate extraction of data and risk of bias assessment. The Newcastle-Ottawa quality assessment scale was used to assess study quality. Three studies fulfilled the inclusion criteria and were analyzed. The total number of participants was 766, with a total follow-up of 923 patient-years. The majority of patients (77%) received a NOAC for atrial arrhythmias, while the remainder were presc
SUBMITTER: Stalikas N
PROVIDER: S-EPMC7356004 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA